Panacea Biotec logo

Panacea Biotec MD, chairman and AGM

NSE: PANACEABIOBSE: 531349Pharmaceuticals & BiotechnologySmall Cap

Panacea Biotec Limited · Face value ₹1 · Listed Jan 1996 on BSE, Apr 1996 on NSE
Last close ₹313.25down ₹12.65 (3.88%)BSE ₹312.95

Share price at the NSE close on 30 Oct 2026. Previous close ₹325.90.

30 Oct: open ₹323.05, high ₹325.95, low ₹311.10

52-week range of traded prices to 30 Oct 2026
₹292.40Low, 30 Mar 2026₹647.00High, 9 Jun 2026
Market cap
₹1,919 Cr1,088th largest listed
P/E
Lossover the last 12 months
P/B
2.30
Dividend yield
Nonein the last 12 months
ROE
−0.9%
ROE without one-offs
−2.2%
ROCE
−3.6%
Debt to equity
0.03
Volume, NSE
57,86658.2% delivered

Panacea Biotec's chairperson and managing director is Rajesh Jain, as filed for the quarter to Sep 2026. Its latest annual general meeting was on 29 Sep 2026.

Panacea Biotec board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • Chairperson and managing directorRajesh Jain
  • Company Secretary and Compliance OfficerAnkit Jain

10 directors5 independent5 executive

  • Rajesh Jain · Chairperson and managing directorExecutive · joined Nov 1984 · reappointed Jan 2025 · 1 listed board
  • Sandeep JainExecutive · joined Nov 1984 · reappointed Apr 2025 · 1 listed board · 1 committee seat
  • Ankesh JainExecutive · joined Apr 2016 · reappointed Apr 2025 · 1 listed board · 1 committee seat
  • Harshet JainExecutive · joined Feb 2025 · reappointed Feb 2025 · 1 listed board
  • Sanjay TrehanExecutive · joined Feb 2025 · reappointed Feb 2025 · 1 listed board · 1 committee seat
  • Ambika SharmaIndependent · joined Feb 2024 · reappointed Feb 2024 · 31 months as independent · 7 listed boards · 7 as independent · 10 committee seats, 2 as chair
  • Krishan Kumar JalanIndependent · joined Feb 2025 · reappointed Feb 2025 · 19 months as independent · 6 listed boards · 6 as independent · 9 committee seats, 3 as chair
  • Rajender Pal SinghIndependent · joined Feb 2025 · reappointed Feb 2025 · 19 months as independent · 2 listed boards · 2 as independent · 1 committee seat
  • Venkatesh SarvasiddhiIndependent · joined Feb 2025 · reappointed Feb 2025 · 19 months as independent · 1 listed board · 1 as independent
  • Rajinder Singh MankuIndependent · joined Jul 2026 · reappointed Jul 2026 · 3 months as independent · 1 listed board · 1 as independent · 1 committee seat

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

4 directors who left
  • Mukul Gupta, left 31 Mar 2026: Tenure Completion
  • Narotam Kumar Juneja, left 31 Mar 2025: Tenure Completion
  • Manjula Upadhyay, left 29 Mar 2025: Tenure Completion
  • Bhupinder Singh, left 16 Oct 2024: Others

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 13 Aug 202610 of 10 present5 independent · 74 days in between
    • 30 May 202610 of 10 present5 independent

  • Audit Committee

    Chair Krishan Kumar Jalan

    Rajender Pal Singh, Rajinder Singh Manku

    • 13 Aug 20263 of 3 present3 independent · 75 days in between
    • 29 May 20263 of 3 present3 independent

  • Nomination and remuneration committee

    Chair Ambika Sharma

    Krishan Kumar Jalan, Rajender Pal Singh

    • 13 Aug 20263 of 3 present3 independent · 75 days in between
    • 29 May 20263 of 3 present3 independent

  • Stakeholders Relationship Committee

    Chair Ambika Sharma

    Sanjay Trehan, Sandeep Jain

    • 13 Aug 20263 of 3 present1 independent · 75 days in between
    • 29 May 20263 of 3 present1 independent

  • Risk Management Committee

    Chair Rajesh Jain

    Sandeep Jain, Ankesh Jain, Sanjay Trehan, Rajender Pal Singh

    • 5 Jun 20264 of 6 present2 independent · 203 days in between
    • 13 Nov 20252 of 5 present0 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • M/s Suresh Surana & Associates LLPPeer-review certificate valid to Mar 2028
1 earlier auditor
  • M/s Suresh Surana & AssociatesNamed in the filing for the quarter to Mar 2025

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Panacea Biotec AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Panacea Biotec dividend history

Annual general meeting, 29 Sep 2026

33,612 shareholders on the register on 22 Sep 2026; present: 2 promoters and 60 others; votes counted by Mr. Debabrata Deb Nath / M/s R&D Company Secretaries.The company's voting result

  1. Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2026 together with the reports of the Board of Directors and the Auditors thereon; and b) Audited Consolidated Financial Statements for financial year ended March 31, 2026 including Auditors’ Report thereonMoreLess
    Ordinary
    99.87% for0.13% against

    Against: promoters 0.00% · institutions 0.02% · other public 70.87%

    Turnout: all 76.53% · promoters 95.76% · institutions 36.10% · other public 0.78%

  2. Re-appointment of retiring director viz. Mr. Ankesh Jain
    OrdinaryPromoters have an interest in it
    99.85% for0.15% against

    Against: promoters 0.00% · institutions 1.36% · other public 70.91%

    Turnout: all 76.53% · promoters 95.76% · institutions 36.10% · other public 0.78%

  3. Re-appointment of retiring director viz. Mr. Harshet Jain
    OrdinaryPromoters have an interest in it
    99.85% for0.15% against

    Against: promoters 0.00% · institutions 1.34% · other public 70.91%

    Turnout: all 76.53% · promoters 95.76% · institutions 36.10% · other public 0.78%

  4. Appointment of Independent Director viz. Mr. Rajinder Singh Manku
    Special
    99.87% for0.13% against

    Against: promoters 0.00% · institutions 0.00% · other public 74.45%

    Turnout: all 76.53% · promoters 95.76% · institutions 36.10% · other public 0.78%

  5. Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for the financial year 2026-27
    Ordinary
    99.87% for0.13% against

    Against: promoters 0.00% · institutions 0.00% · other public 70.89%

    Turnout: all 76.53% · promoters 95.76% · institutions 36.10% · other public 0.78%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 30 Sep 2025, 5 resolutions

34,241 shareholders on the register on 23 Sep 2025; present: 2 promoters and 67 others; votes counted by Mr. Debabrata Deb Nath / M/s R&D Company Secretaries.The company's voting result

  1. Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2025 together with the reports of the Board of Directors and the Auditors thereon; and b) Audited Consolidated Financial Statements for financial year ended March 31, 2025 including Auditors’ Report thereonMoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 78.93% · promoters 99.90% · institutions 25.54% · other public 1.03%

  2. Re-appointment of retiring director Dr. Rajesh Jain
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 78.93% · promoters 99.90% · institutions 25.54% · other public 1.03%

  3. Re-appointment of retiring director Mr. Sandeep Jain
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 78.93% · promoters 99.90% · institutions 25.54% · other public 1.03%

  4. Appointment of M/s R&D Company Secretaries as Secretarial Auditors of the Company
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 78.93% · promoters 99.90% · institutions 25.54% · other public 1.03%

  5. Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for the financial year 2025-26
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 78.93% · promoters 99.90% · institutions 25.54% · other public 1.03%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 29 Mar 2025, 7 resolutions

34,957 shareholders on the register on 21 Feb 2025; votes counted by Mr. Debabrata Deb Nath / R & D Company Secretaries.The company's voting result

  1. Re-appointment of Mr. Sandeep Jain (DIN: 00012973) as Joint Managing Director for a period of 3 years w.e.f. April 01, 2025
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.12%

    Turnout: all 78.54% · promoters 99.90% · institutions 1.26% · other public 1.89%

  2. Re-appointment of Mr.Ankesh Jain (DIN: 03556647) as Whole-time Director for a period of 5 years w.e.f. April 01, 2025.
    OrdinaryPromoters have an interest in it
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 100.00% · other public 0.13%

    Turnout: all 78.54% · promoters 99.90% · institutions 1.26% · other public 1.89%

  3. Appointment of Mr. Harshet Jain (DIN: 08732974) as Whole-time Director for a period of 3 years w.e.f. February 14, 2025.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.12%

    Turnout: all 78.54% · promoters 99.90% · institutions 1.26% · other public 1.89%

  4. Appointment of Dr. Sanjay Trehan (DIN:10936402) as Whole-time Director for a period of 3 years w.e.f. February 14, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.13%

    Turnout: all 78.54% · promoters 99.90% · institutions 1.26% · other public 1.89%

  5. Appointment of Mr. Krishan Kumar Jalan (DIN: 01767702) as non-executive Independent Director for a period of 5 consecutive years w.e.f. February 14, 2025
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.14%

    Turnout: all 78.54% · promoters 99.90% · institutions 1.26% · other public 1.89%

  6. Appointment of Dr. Rajender Pal Singh (DIN: 10198810) as non-executive Independent Director for a period of 5 consecutive years w.e.f. February 14, 2025
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.14%

    Turnout: all 78.54% · promoters 99.90% · institutions 1.26% · other public 1.89%

  7. Appointment of Mr. Venkatesh Sarvasiddhi (DIN: 09326552) as non-executive Independent Director for a period of 5 consecutive years w.e.f. February 14, 2025
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.31%

    Turnout: all 78.54% · promoters 99.90% · institutions 1.26% · other public 1.89%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 26 Dec 2024, 3 resolutions

36,776 shareholders on the register on 22 Nov 2024; votes counted by Debabrata Deb Nath / R&D Company Secretaries.The company's voting result

  1. Re-appointment of Dr. Rajesh Jain (DIN: 00013053) as Chairman and Managing Director for a period of 3 years w.e.f. January 01, 2025
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.06%

    Turnout: all 78.58% · promoters 99.90% · institutions 0.01% · other public 1.41%

  2. Appointment of Mr. Rajesh Jain (DIN: 10619014), Chartered Accountant as a non-executive Independent Director for a period of 5 consecutive years w.e.f. November 13, 2024
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.29%

    Turnout: all 78.58% · promoters 99.90% · institutions 0.01% · other public 1.41%

  3. Approval for making donation / contribution to bonafide and Charitable Trust
    Ordinary
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 100.00% · other public 2.57%

    Turnout: all 78.58% · promoters 99.90% · institutions 0.01% · other public 1.41%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 27 Sep 2024, 5 resolutions

Present: 2 promoters and 61 others.

  1. Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2024 and b) Audited Consolidated Financial Statements for financial year ended March 31, 2024 and the report of Board of Director and Auditors.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.20%

    Turnout: all 78.78% · promoters 100.00% · institutions 0.03% · other public 1.06%

  2. Re-appointment of retiring director i.e. Mr. Narotam Kumar Juneja, for a period upto March 31, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.25%

    Turnout: all 78.78% · promoters 100.00% · institutions 0.03% · other public 1.06%

  3. Appointment of M/s Suresh Surana & Associates LLP, Chartered Accountants as Statutory Auditors and fixation of their remuneration
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.24%

    Turnout: all 78.78% · promoters 100.00% · institutions 0.03% · other public 1.06%

  4. Consider and approve re-classification from Promoters and Promoters' Group category to Public category
    OrdinaryPromoters have an interest in it
    99.77% for0.23% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.24%

    Turnout: all 0.21% · promoters 0.00% · institutions 0.03% · other public 1.03%

  5. Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for the financial year 2024-25
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.22%

    Turnout: all 78.78% · promoters 100.00% · institutions 0.03% · other public 1.06%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 11 Apr 2024, 2 resolutions
  1. Appointment of Mrs. Ambika Sharma (DIN: 08201798) as Non-Executive Independent Director
    Special
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.00% · other public 2.91%

    Turnout: all 79.30% · promoters 99.67% · institutions 0.02% · other public 2.30%

  2. Re-appointment of Mr. Bhupinder Singh (DIN: 00062754) as Non-Executive Independent Director
    Special
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.00% · other public 3.44%

    Turnout: all 79.30% · promoters 99.67% · institutions 0.02% · other public 2.30%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 29 Sep 2023, 4 resolutions

Present: 2 promoters and 48 others.

  1. Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2023 andn(b) Audited Consolidated Financial Statements for financial year ended March 31, 2023:
    Ordinary
    99.95% for0.05% against

    Against: promoters 0.00% · institutions 0.00% · other public 50.91%

    Turnout: all 79.10% · promoters 99.91% · institutions 0.02% · other public 0.38%

  2. Re-appointment of retiring director i.e. Mr. Sandeep Jain
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.67%

    Turnout: all 79.10% · promoters 99.91% · institutions 0.02% · other public 0.38%

  3. Re-appointment of retiring director i.e. Mr. Ankesh Jain
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.74%

    Turnout: all 79.10% · promoters 99.91% · institutions 0.02% · other public 0.38%

  4. Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for the financial year 2023-24:
    Ordinary
    99.95% for0.05% against

    Against: promoters 0.00% · institutions 0.00% · other public 51.54%

    Turnout: all 79.10% · promoters 99.91% · institutions 0.02% · other public 0.38%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 28 Sep 2022, 4 resolutions

Present: 1 promoter and 53 others.

  1. Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2022 and (b) Audited Consolidated Financial Statements for financial year ended March 31, 2022:
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.12%

    Turnout: all 76.27% · promoters 96.22% · institutions 0.05% · other public 0.78%

  2. Re-appointment of retiring director i.e. Mr. Soshil Kumar Jain
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.08%

    Turnout: all 76.27% · promoters 96.22% · institutions 0.05% · other public 0.78%

  3. Re-appointment of retiring director i.e. Dr. Rajesh Jain
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 1.00%

    Turnout: all 76.27% · promoters 96.22% · institutions 0.05% · other public 0.78%

  4. Ratification of remuneration of M/s GT & Co., Cost Auditors for the financial year 2022-23
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.38%

    Turnout: all 76.27% · promoters 96.22% · institutions 0.05% · other public 0.78%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.

Mutual fund votes, meeting of 29 Sep 2026, 2 fund houses

  • Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2026 together with the reports of the Board of Directors and the Auditors thereon; and b) Audited Consolidated Financial Statements for financial year ended March 31, 2026 including Auditors’ Report thereonMoreLess
    Against Bandhan Mutual Fund
    • Bandhan Mutual FundUnqualified standalone financial statements. Non-Compliant with the Companies Act, 2013 & SEBI LODR Regulations: Non-disclosure of financial statements of the Subsidiary Companies for FY 2025-26 on the Company’s website.
    1 for1 against
  • Re-appointment of retiring director viz. Mr. Ankesh Jain
    Against Bandhan Mutual Fund
    • Bandhan Mutual FundCompliant with law. No concern identified w.r.t. the merits of the director. Governance Concern: Low attendance at board meetings in aggregate in last 3 FYs and no reason provided for absence.
    1 for1 against
  • Re-appointment of retiring director viz. Mr. Harshet Jain
    2 for0 against
  • Appointment of Independent Director viz. Mr. Rajinder Singh Manku
    2 for0 against
  • Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for the financial year 2026-27
    2 for0 against

Mutual fund votes, meeting of 30 Sep 2025, 2 fund houses

  • Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2025 together with the reports of the Board of Directors and the Auditors thereon; and b) Audited Consolidated Financial Statements for financial year ended March 31, 2025 including Auditors’ Report thereonMoreLess
    2 for0 against
  • Re-appointment of retiring director Dr. Rajesh Jain
    2 for0 against
  • Re-appointment of retiring director Mr. Sandeep Jain
    2 for0 against
  • Appointment of M/s R&D Company Secretaries as Secretarial Auditors of the Company
    2 for0 against
  • Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for the financial year 2025-26
    2 for0 against

Mutual fund votes, meeting of 27 Sep 2024, 2 fund houses

5 proposals
  • Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2024 and b) Audited Consolidated Financial Statements for financial year ended March 31, 2024 and the report of Board of Director and Auditors.MoreLess
    2 for0 against
  • Re-appointment of retiring director i.e. Mr. Narotam Kumar Juneja, for a period upto March 31, 2025
    2 for0 against
  • Appointment of M/s Suresh Surana & Associates LLP, Chartered Accountants as Statutory Auditors and fixation of their remuneration
    2 for0 against
  • Consider and approve re-classification from Promoters and Promoters' Group category to Public category
    2 for0 against
  • Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for the financial year 2024-25
    2 for0 against

Mutual fund votes, meeting of 11 Apr 2024, 1 fund house

2 proposals
  • Appointment of Mrs. Ambika Sharma (DIN: 08201798) as Non-Executive Independent Director
    1 for0 against
  • Re-appointment of Mr. Bhupinder Singh (DIN: 00062754) as Non-Executive Independent Director
    1 for0 against

Mutual fund votes, meeting of 29 Sep 2023, 1 fund house

4 proposals
  • Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2023 andn(b) Audited Consolidated Financial Statements for financial year ended March 31, 2023:
    1 for0 against
  • Re-appointment of retiring director i.e. Mr. Sandeep Jain
    1 for0 against
  • Re-appointment of retiring director i.e. Mr. Ankesh Jain
    1 for0 against
  • Ratification of remuneration of M/s Jain Sharma & Associates, Cost Auditors for the financial year 2023-24:
    1 for0 against

Mutual fund votes, meeting of 28 Sep 2022, 1 fund house

4 proposals
  • Consider and adopt: a) Audited Standalone Financial Statements for financial year ended March 31, 2022 and (b) Audited Consolidated Financial Statements for financial year ended March 31, 2022:
    1 for0 against
  • Re-appointment of retiring director i.e. Mr. Soshil Kumar Jain
    1 for0 against
  • Re-appointment of retiring director i.e. Dr. Rajesh Jain
    1 for0 against
  • Ratification of remuneration of M/s GT & Co., Cost Auditors for the financial year 2022-23
    1 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Tax disputes

Reported in the filing for the quarter to Sep 2026.

  • Tax disputeCentral Excise, New DelhiSince 2 Sep 2010
    The matter is pending before the Delhi High Court. No change during the quarter.
    At the filing before: The Company filed rebate claims of Excise Duty before the Assistant Commsioner of Central Excise which was partly allowed in the form of CENVAT Credit amounting to ₹3.46 million instead of repayment in cash. PBL filed an appeal before Commissioner (Appeals) wherein repayment of claims in cash was allowed and the same was credited into Company's Account. However, Department filed revision application with Joint Secretary, Government of India against the said order which was accepted in favour of Department. Then, the Company filed writ petition before the Delhi High Court against such decision and the same was admitted.MoreLess
  • Tax disputeUnion of India represented through Commissioner of Central GST, Delhi EastSince 8 Feb 2012
    The matter is pending before Hon'ble Supreme Court. No change during the quarter.
    At the filing before: Show Cause Notice (SCN) dated 08-02-2012 for ₹12.94 million was issued by Commissioner of Central Excise Chandigarh alleging availment of ineligible CENVAT Credit. The Company filed a Writ Petition for quashing of SCN. Hon’ble High Court of Punjab and Haryana allowed Writ Petition vide Order dated 26-11-2019 and quashed the SCN. Union of India represented through Commissioner of Central GST, Delhi East preferred Special Leave Petition (SLP) before Hon’ble Supreme Court of India on 22-12-2020 against the High Court’s Order. The Company has requested the concerned Deputy Commissioner, CGST (Derabassi) to file suitable application to withdraw the SLP as per the instructions issued by the CBIC under Section 35R of the Central Excise Act 1944, prohibiting filing of appeals etc. by the Department to higher Authorities when the amount of taxes involved is less than the prescribed limits.MoreLess
  • Tax disputeCommissioner of Central GST, New DelhiSince 29 Jan 2015
    The matter is pending before the Hon'ble Delhi High Court. No change during the quarter.
    At the filing before: Demand Order of ₹62.50 million with penalty and interest of ₹8.10 million was issued by the Commissioner of Central Excise, Delhi on account of non-payment of service tax u/s 68 on gross value of taxable services. The Company filed an appeal before Customs, Excise & Service Tax Appellate Tribunal, Delhi (“CESTAT”) against the said demand order which was allowed by CESTAT. However, Commissioner of Central GST, New Delhi preferred an appeal before the Hon'ble Delhi High Court (“DHC”) on 30-09-2020 which was rejected vide its order dated 10-09-2024. Thereafter, the said Commissioner then filed a Review Petition on 15-11-2024 before DHC against order dated 10-09-2024.MoreLess
  • Tax disputeDeputy Commissioner of Income Tax, Central Circle-05, New DelhiSince 30 Apr 2021
    The appeal before the Hon'ble Delhi High Court is pending at present. No change during the quarter.
    At the filing before: Demand of ₹33.69 million was raised by Income tax department vide its order dated 30-04-2021 on account of disallowance made by transfer pricing officer on purchases from / payment of expenses to, related parties in Assessment Year 2016-17. The Company filed an appeal before ITAT and case was decided in favour of the Company. Department filed an appeal against the ITAT order before the Hon'ble Delhi High Court.MoreLess
  • Tax disputeOffice of the State Tax Officer, MaharashtraSince 16 Jul 2024
    The matter is pending before Deputy Commissioner (Appeals). No change during the quarter.
    At the filing before: Demand of ₹3.8 million was raised on Company's wholly owned subsidiary, Panacea Biotec Pharma Ltd. ("PBPL") by GST Department vide its order dated 16-07-2024 for the financial year 2019-20 on account of excess claim of Input Tax Credit of ineligible services and non-payment of GST under reverse charge mechanism on various expenses. PBPL filed an appeal before Deputy Commissioner (Appeals) on 30-09-2024 against the demand order.MoreLess
  • Tax disputeOffice of Assistant Commissioner of State Tax, GST, Porur, Tamil NaduSince 22 Feb 2025
    The appeal before the Deputy Commissoner of State Tax is pending. No change during the quarter.
    At the filing before: Demand of ₹8.81 million was raised by GST Department vide its order dated 22-02-2025 in the name of PBPL, comprising of GST along with interest and penalty thereon, on account of claiming excess input tax credit in its GST returns for the FY 2020-21. PBPL filed an appeal against the said demand order on 20-05-2025 before the Deputy Commissioner of State Tax, Tamil Nadu.MoreLess
  • Tax disputeOffice of the State Tax Officer, Mazgaon, Mumbai, MaharashtraSince 25 Feb 2025
    PBPL filed appeal before the GST Appellate Tribunal on 21-07-2026.
    At the filing before: Demand of ₹15.82 million was raised by GST Department vide its order dated 25-02-2025 in the name of PBPL, comprising of GST along with interest and penalty thereon, on account of claiming excess input tax credit in its GST return for the FY 2020-21. PBPL filed an appeal against the said demand order on 16-05-2025 before the Deputy Commissioner of State Tax, Maharashtra. Order dated 10-03-2026 was issued by Deputy Commissioner of State Tax, Maharashtra, reducing total demand from ₹15.82 million to ₹8.15 million.MoreLess
  • Tax disputeOffice of Assistant Commissioner of Income Tax, DelhiSince 22 Mar 2025
    The matter is pending before ITAT. No change during the quarter.
    At the filing before: Demand of ₹6.36 million was raised by Income Tax department vide its order dated 22-03-2025 on account of disallowance of certain expenditure for the Asesstment Year 2023-24. The Company filed an appeal with CIT(A) against such Order. CIT(A) dismissed the appeal. The Company filed an appeal on 13-04-2026 before ITAT against the order of CIT(A) dated 26-02-2026.MoreLess
7 more
  • Tax disputeOffice of the Assistant Commissioner of State Tax, GST Bhawan, Mazgaon, Mumbai, MaharashtraSince 10 Jul 2025
    The matter is pending before the Hon'ble Bombay High Court.
    At the filing before: Demand Order of ₹70.34 million was received from the Assistant Commissioner of State Tax, Mumbai towards balance amount of Goods and Service Tax ("GST") (including interest & penalty thereon) on assignment of leasehold rights in land and building by the Company in Navi Mumbai. The Company filed writ petition before the Hon’ble Bombay High Court, challenging the said Order on 04-09-2025. The Hon'ble High Court issued an interim order dated 25-02-2026 pursuant to which the authority has been directed that pending the hearing and final disposal of the petition, no recovery under the impugned orders shall be adopted against the Company. The Company filed a refund application on 03-04-2026 before Maharashtra GST Authorities for seeking refund of tax & interest paid under protest amounting to ₹31.4 million. Thereafter, a show cause notice was received by the Company in relation to the refund application which was replied suitably.MoreLess
  • Tax disputeOffice of the Commissioner, Central GST (Audit) Commissionerate, PunjabSince 26 Sep 2025
    The matter is pending before the Hon'ble Punjab & Haryana High Court.
    At the filing before: Show cause notice (SCN) was issued under the Central Goods and Services Tax Act, 2017 (CGST Act) regarding alleged non-payment of GST of ₹114.40 million on providing Corporate Guarantee amounting to ₹8,640 million to Debenture Trustee viz. Vistra ITCL (India) Limited in relation to transfer of pharmaceutical formulations business to the Company’s wholly owned subsidiary viz. Panacea Biotec Pharma Limited, for 1,074 days from 06-04-2019 to 15-03-2022. The Company filed writ petition before the Hon’ble Punjab & Haryana High Court on 24-11-2025, challenging the said Order. The Hon'ble High Court passed an interim stay order stating inter-alia that no coercive action be taken against the Company in case of final assessment order is passed or a demand is raised. In the meantime, Joint Commissioner, CGST Sub-Commissionerate Mohali, Chandigarh issued a Demand Order dated 30-03-2026 raising demand aggregating to ~₹228.80 million (towards alleged non-payment of GST of ~₹114.40 million and penalty of ~₹114.40 million). The Company has filed an appeal on 25-06-2026 before the First Appellate Authority against the order dated 30-03-2026.MoreLess
  • Tax disputeAssistant Commissioner of Income Tax, New DelhiSince 24 Dec 2025
    The matter is pending before ITAT. No change during the quarter.
    At the filing before: Demand aggregating to ₹93.88 million was raised by Income Tax department vide its three Demand Orders dated 24-12-2025, imposing penalty on account of alleged under reporting of income. The Company filed appeals with Commissioner of Income Tax (Appeals) ("CIT(A)") against the said Demand Order. The CIT(A) has dismissed the appeals vide its order dated 25-03-2026. The Company has filed an appeal with ITAT on 11-05-2026.MoreLess
  • Tax disputeState Tax Officer, MaharashtraSince 6 Oct 2025
    The matter is pending before the State Tax Officer, Maharashtra.
    At the filing before: Show Cause Notice was issued to PBPL for the financial year 2022-23 alleging reversal/payment of Input Tax Credit amounting to ₹8.27 million on account of mismatch of ITC availed in GSTR-3B vis-à-vis GSTR 2A. PBPL filed a reply against the aforesaid notice on 02-12-2025.MoreLess
  • Tax disputeAssistant Commissioner of State Tax, GST, DelhiSince 23 Jul 2026
    The matter is pending before the Assistant Commissioner of State Tax, GST, Delhi.
    At the filing before: Show Cause Notice was issued to PBPL under Section 73 of Delhi Goods & Services Tax / Central Goods & Services Tax Act & Rules, 2017 alleging total tax liability of ₹40.6 million including interest, tax and penalty, on account of alleged excess claim of Input Tax Credit in the Annual Return filed for the Financial Year 2022-23. PBPL filed a reply against the said notice on 23-08-2026.MoreLess
  • Tax disputeAssistant Commissioner of Income Tax, New DelhiSince 25 Sep 2026
    The said demand is not maintainable, and the Company is taking all necessary steps including filing an Appeal with appellate authority against the said Demand Orders.
    At the filing before: Demand aggregating to ₹98.15 million was raised by Income Tax department vide its four Demand Orders dated 25-09-2026 for Assessment Years from 2014-15 to 2016-17 and 2018-19, imposing penalty on account of alleged misreporting / under reporting of income.MoreLess
  • Tax disputeAssistant Commissioner of Income Tax, New DelhiSince 28 Sep 2026
    The said demand is not maintainable, and the Company is taking all necessary steps including filing an Appeal with appellate authority against the said Demand Orders.
    At the filing before: Demand aggregating to ₹43.15 million was raised by Income Tax department vide its two Demand Orders dated 28-09-2026 for Assessment Years 2022-23 and 2023-24, imposing penalty on account of alleged misreporting / under reporting of income.MoreLess

In the company's own words, from its latest governance filing.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved
00Dec 2400Mar 2500Jun 2500Sep 2500Dec 2500Mar 2600Jun 2600Sep 26

Open at the quarter's end

0Dec 240Mar 250Jun 250Sep 250Dec 250Mar 260Jun 260Sep 26
None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
Yes
There was a cyber security incident in the quarter
No

The company's own answers in its filing.